RSR LIMITED
- Shared products
- ANTI-INSULIN ANTIBODY, ANTICORPO ANTI-DESCARBOXILASE DE ÁCIDO GLUTÂMICO (GAD), ANTICORPO ANTI-INSULINA
- Shared products
- ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY, ANTI-INSULIN ANTIBODY
- Shared products
- ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY, ANTI-MICROSOMAL ANTIBODIES
- Shared products
- ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY, ANTI-INSULIN ANTIBODY
- Shared products
- ANTI-GLUTAMIC ACID DECARBOXYLASE (GAD) ANTIBODY, ANTI-INSULIN ANTIBODY
Explore comprehensive manufacturer profile for RSR LIMITED based in United Kingdom through Pure Global AI's free Brazil medical device database. This manufacturer has 3 products registered with ANVISA across 3 unique technical categories. Their regulatory history spans from May 06, 1999 to Apr 20, 2015.
This page provides detailed insights including 3 recent product registrations including ANTI-INSULIN ANTIBODY, 3 most popular products with ANTI-INSULIN ANTIBODY having 1 registrations, 1 registration holders including GENESE PRODUTOS DIAGNOSTICOS LTDA, and 5 key competitors with SHENZHEN YHLO BIOTECH CO., LTD. sharing 3 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.